The Once and Future Application of Cost-Effectiveness Analysis

Gold, 1996 Haddix, 1996 Tengs, 1996, The opportunity costs of haphazard social investments in life-saving, 167 Pauley, 1999, Why should managed care be regulated?, 53 Berger, 1998, Willingness to pay versus willingness to buy: What defines value in healthcare?, Value in Health, 1, 201, 10.1046/j.1524-4733.1998.140201.x Davis, 1995, Choice matters: Enrollees’ views of their health plans, Health Aff, 14, 99, 10.1377/hlthaff.14.2.99 Patrick, 1997, Dissatisfaction and disenrollment in a subsidized managed care program, Medical Care Research and Review, 54, 61, 10.1177/107755879705400104 1998 Tengs, 1995, Five hundred life-saving interventions and their cost-effectiveness, Risk Anal, 15, 369, 10.1111/j.1539-6924.1995.tb00330.x Lyles, 1997, Managed care pharmacy, socioeconomic assessments and drug adoption decisions, Soc Sci Med, 54, 511, 10.1016/S0277-9536(96)00392-9 National Committee for Quality Assurance: HEDIS 3.0 Narrative: What’s in It and Why It Matters. Washington, DC, 1997. Hadorn, 1991, Setting health care priorities in Oregon: Cost-effectiveness meets the rule of rescue, JAMA, 265, 2218, 10.1001/jama.1991.03460170072036 Singer, 1997, Resource allocation: Beyond evidence-based medicine and cost-effectiveness analysis, ACP Journal Club, 127, A16, 10.7326/ACPJC-1997-127-3-A16 Daniels, 1998, Last Chance Therapies and Managed Care: Pluralism, Fair Procedures, and Legitimacy, Hastings Cent Rep, 28, 25, 10.2307/3527569 Daniels, 1997, Limits to health care: Fair procedures, democratic deliberation, and the legitimacy problem for insurers, Philosophy and Public Affairs, 26, 303, 10.1111/j.1088-4963.1997.tb00082.x